BeOne Medicines (ONC) Change in Accured Expenses (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Change in Accured Expenses data on file, last reported at $1.7 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 103.31% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (up 503.24% YoY) and the FY2025 annual result came in at $19.0 million, up 227.83% from the prior year.
• Change in Accured Expenses eased to $1.7 million in Q1 2026 per ONC's latest filing, from $15.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $128.0 million in Q2 2025 and bottomed at -$79.3 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $197000.0 (2023), against an average of $3.1 million.
• The widest annual swing landed in 2022, when Change in Accured Expenses jumped 3364.56%; it then plunged 40358.38% in 2024.
• Tracing ONC's Change in Accured Expenses over 5 years: stood at $44.0 million in 2022, then plunged by 212.51% to -$49.5 million in 2023, then surged by 70.28% to -$14.7 million in 2024, then jumped by 204.81% to $15.4 million in 2025, then slumped by 88.77% to $1.7 million in 2026.
• Per Business Quant, the three latest ONC Change in Accured Expenses figures stand at $1.7 million (Q1 2026), $15.4 million (Q4 2025), and -$72.1 million (Q3 2025).

Peer Comparison